Edessa review
Headline is a prepay rate
Edessa's homepage leads with $135. That figure is what you pay if you buy six months up front; a month at a time costs $179.
Our verdict
Edessa publishes its full plan table, which is more than most sellers do, and the table is where the real number is. The homepage headline of $135 is the six-month prepay rate. Month-to-month is $179, three months is $160. None of that is hidden — it is just not what the front page says.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- States
- 51
- Availability
- 51 states
- Updated
- September 2026
What it is
A telehealth service selling compounded semaglutide and tirzepatide across fifty-one states, in both injectable and oral form. Each product has its own page with a plan table showing one-month, three-month and six-month pricing side by side.
How it works
Prescription-gated, with the plan chosen at purchase rather than after a consult. The commitment length is the main variable: the longer you buy, the lower the per-month figure, which is why the headline and the month-to-month rate differ by $44.
Pricing transparency
Injectable semaglutide is $179 a month, $160 on a three-month plan and $135 on six months. The oral tablet is $229, $209 and $199 on the same terms. Tirzepatide injection is $239, $219 and $209. The price does not change as your dose escalates.
Branded vs compounded
Compounded semaglutide and tirzepatide, not the branded products. The tablet page describes what you receive as compounded semaglutide medication. Compounded drugs are not FDA-approved or reviewed for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- Publishes the full plan table rather than one headline figure
- Oral and injectable priced separately and openly
- Price holds as the dose climbs
- Fifty-one states
Watch-outs
- The homepage figure is the six-month rate, not the monthly one
- Month-to-month costs $44 more than the number on the front page
- The oral tablet is $50 dearer than the injection, not cheaper
Best for
Buyers who know they will stay six months and want the lower rate that comes with committing to it.
Who should look elsewhere
Anyone wanting to try a month and stop. The month-to-month price is the one to compare, and it is not the advertised one.
How Edessa compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak
Flat dose pricing without a subscription
See Oak → - Synergy Rx
Both molecules in both forms
See Synergy Rx → - Care Bare Rx
A single entry price, if you are starting on semaglutide
See Care Bare Rx →
More compounded semaglutide sellers reviews: KERNX HealthLean MedsLongevixxMaximusMEDGmMondae
Pricing & provider data · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Edessa’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does Edessa actually cost per month?
- $179 for injectable compounded semaglutide if you pay month to month. The $135 on the homepage is the rate for buying six months up front, and $160 is the three-month rate. The oral tablet is $229 month to month and tirzepatide injection is $239.
- Is the oral tablet cheaper than the injection?
- No. Edessa's oral semaglutide is $229 a month against $179 for the injection — $50 more for the tablet. Oral GLP-1s are widely marketed as the accessible option, but sellers price the two forms independently and the direction is not consistent.
- Does the price go up as my dose increases?
- No. Edessa holds one price across every dose, so the figure you start on is the figure you pay at a maintenance dose. Over a year that policy is often worth more than a lower opening rate at a seller that re-prices at each titration step.
- Is Edessa's semaglutide FDA-approved?
- No. It is compounded semaglutide, prepared by a compounding pharmacy against a prescription. Compounded drugs are not FDA-approved and are not reviewed for safety, efficacy or quality before they are dispensed. That is true regardless of which plan you buy.
- Is Edessa legit?
- Edessa is a compounded semaglutide sellers service. Its stated availability: 51 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Edessa expensive compared with other compounded semaglutide sellers providers?
- Edessa publishes a starting figure of $179/mo. Across the 59 compounded semaglutide sellers providers we review that publish a single monthly figure, those run $79 to $369 with a median of $150, which puts Edessa above the median. The other 1 compounded semaglutide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.